retapamulin · Almirall · NDA 022055
Altabax
Earliest generic entry, as listed
14 Feb 2027
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 7875630.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7875630 | drug substance · sets the listed date | 14 Feb 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Enters 12-month window basis: patent · 022055-001Listed date 14 Feb 2027Detected 24 Oct 2026
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022055 · 001 · RLD · discontinued | ointment, topical | 1% | 14 Feb 2027 |